Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane‐Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl)

The cytotoxic activity of combinations of masticadienonic (AMD) or 3αOH‐hydroxy‐masticadienonic (3αOH‐AMD) acids with cisplatin (CDDP) was evaluated against PC3 prostate and HCT116 colon cancer cell lines. Combinations A (half the IC50 value), B (IC50 value), and C (twice the IC50 value) were tested...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chemistry & biodiversity 2023-10, Vol.20 (10), p.e202300893-n/a
Hauptverfasser: Díaz‐Sánchez, Lidia, Zentella‐Dehesa, Alejandro, Castro‐Torres, Víctor Alberto, Silva‐Jiménez, Noemi, Jacobo‐Herrera, Nadia Judith, Martínez‐Vázquez, Mariano
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 10
container_start_page e202300893
container_title Chemistry & biodiversity
container_volume 20
creator Díaz‐Sánchez, Lidia
Zentella‐Dehesa, Alejandro
Castro‐Torres, Víctor Alberto
Silva‐Jiménez, Noemi
Jacobo‐Herrera, Nadia Judith
Martínez‐Vázquez, Mariano
description The cytotoxic activity of combinations of masticadienonic (AMD) or 3αOH‐hydroxy‐masticadienonic (3αOH‐AMD) acids with cisplatin (CDDP) was evaluated against PC3 prostate and HCT116 colon cancer cell lines. Combinations A (half the IC50 value), B (IC50 value), and C (twice the IC50 value) were tested at a 1 : 1 ratio. All AMD plus CDDP combinations demonstrated increased cytotoxic effect, as determined by the sulforhodamine B test, in both cell types. The best combination was B, which showed 93 % and 91 % inhibition of the proliferation of PC3 and HCT116 cells, respectively. It also increased apoptosis in the PC3 cell lines, as evaluated by flow cytometry. However, in vivo tests showed no additional activity from the AMD plus CDDP combinations. These results showed that the increased cytotoxic activity of the combinations in vitro did not reflect in vivo tests. All combinations of 3αOH‐AMD plus CDDP exerted antagonistic effects in both cell types.
doi_str_mv 10.1002/cbdv.202300893
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2864157671</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2864157671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3453-4ba19f8531722444e4fbf2ffa2cb1ce4e6430b556d1df11728c47c07a1fedfd63</originalsourceid><addsrcrecordid>eNqF0btOwzAUBuAIgcR1ZbbEAkOLb7l0LKFcJCQGCmvk2MdglNjBToq68QgMPCFPgqEIJBYm28fff2TrJMk-wWOCMT2WtVqMKaYM42LC1pItkhE6IkWB13_2Od1MtkN4jD7Wi63kbbYQzSB642xATqOp7Y0UVoJHM61B9l_V0rW1sb-qNKFr4tEiYRWaGz9I0TTCwvvL63zZAZp704PvwEJAl8FFCwpp71o0bbsH08XL5b0ZWiRU6L2x9xAbH97Ih6ZXzdFusqFFE2Dve91Jbs9m8_JidHV9fllOr0aS8ZSNeC3IRBcpIzmlnHPgutZUa0FlTSRwyDjDdZpmiihNIiokzyXOBdGgtMrYTnK46tt59zRA6KvWBAlfP3FDqGiRcZLmWU4iPfhDH93gbXxdVPmEM8YzHNV4paR3IXjQVedNK_yyIrj6HFL1OaTqZ0gxMFkFnk0Dy390VZ6c3v1mPwBW7Jnt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2879433460</pqid></control><display><type>article</type><title>Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane‐Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl)</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Díaz‐Sánchez, Lidia ; Zentella‐Dehesa, Alejandro ; Castro‐Torres, Víctor Alberto ; Silva‐Jiménez, Noemi ; Jacobo‐Herrera, Nadia Judith ; Martínez‐Vázquez, Mariano</creator><creatorcontrib>Díaz‐Sánchez, Lidia ; Zentella‐Dehesa, Alejandro ; Castro‐Torres, Víctor Alberto ; Silva‐Jiménez, Noemi ; Jacobo‐Herrera, Nadia Judith ; Martínez‐Vázquez, Mariano</creatorcontrib><description>The cytotoxic activity of combinations of masticadienonic (AMD) or 3αOH‐hydroxy‐masticadienonic (3αOH‐AMD) acids with cisplatin (CDDP) was evaluated against PC3 prostate and HCT116 colon cancer cell lines. Combinations A (half the IC50 value), B (IC50 value), and C (twice the IC50 value) were tested at a 1 : 1 ratio. All AMD plus CDDP combinations demonstrated increased cytotoxic effect, as determined by the sulforhodamine B test, in both cell types. The best combination was B, which showed 93 % and 91 % inhibition of the proliferation of PC3 and HCT116 cells, respectively. It also increased apoptosis in the PC3 cell lines, as evaluated by flow cytometry. However, in vivo tests showed no additional activity from the AMD plus CDDP combinations. These results showed that the increased cytotoxic activity of the combinations in vitro did not reflect in vivo tests. All combinations of 3αOH‐AMD plus CDDP exerted antagonistic effects in both cell types.</description><identifier>ISSN: 1612-1872</identifier><identifier>EISSN: 1612-1880</identifier><identifier>DOI: 10.1002/cbdv.202300893</identifier><language>eng</language><publisher>Weinheim: Wiley Subscription Services, Inc</publisher><subject>Anticancer properties ; antitumor ; Apoptosis ; Biomedical materials ; Cell proliferation ; Cisplatin ; Colon cancer ; combinations ; cytotoxic ; Cytotoxicity ; Flow cytometry ; In vivo methods and tests ; Prostate cancer ; Sulforhodamine ; triterpene ; Triterpenes ; Tumor cell lines</subject><ispartof>Chemistry &amp; biodiversity, 2023-10, Vol.20 (10), p.e202300893-n/a</ispartof><rights>2023 The Authors. Chemistry &amp; Biodiversity published by Wiley‐VHCA AG, Zurich, Switzerland</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3453-4ba19f8531722444e4fbf2ffa2cb1ce4e6430b556d1df11728c47c07a1fedfd63</cites><orcidid>0000-0002-5595-1466</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcbdv.202300893$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcbdv.202300893$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids></links><search><creatorcontrib>Díaz‐Sánchez, Lidia</creatorcontrib><creatorcontrib>Zentella‐Dehesa, Alejandro</creatorcontrib><creatorcontrib>Castro‐Torres, Víctor Alberto</creatorcontrib><creatorcontrib>Silva‐Jiménez, Noemi</creatorcontrib><creatorcontrib>Jacobo‐Herrera, Nadia Judith</creatorcontrib><creatorcontrib>Martínez‐Vázquez, Mariano</creatorcontrib><title>Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane‐Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl)</title><title>Chemistry &amp; biodiversity</title><description>The cytotoxic activity of combinations of masticadienonic (AMD) or 3αOH‐hydroxy‐masticadienonic (3αOH‐AMD) acids with cisplatin (CDDP) was evaluated against PC3 prostate and HCT116 colon cancer cell lines. Combinations A (half the IC50 value), B (IC50 value), and C (twice the IC50 value) were tested at a 1 : 1 ratio. All AMD plus CDDP combinations demonstrated increased cytotoxic effect, as determined by the sulforhodamine B test, in both cell types. The best combination was B, which showed 93 % and 91 % inhibition of the proliferation of PC3 and HCT116 cells, respectively. It also increased apoptosis in the PC3 cell lines, as evaluated by flow cytometry. However, in vivo tests showed no additional activity from the AMD plus CDDP combinations. These results showed that the increased cytotoxic activity of the combinations in vitro did not reflect in vivo tests. All combinations of 3αOH‐AMD plus CDDP exerted antagonistic effects in both cell types.</description><subject>Anticancer properties</subject><subject>antitumor</subject><subject>Apoptosis</subject><subject>Biomedical materials</subject><subject>Cell proliferation</subject><subject>Cisplatin</subject><subject>Colon cancer</subject><subject>combinations</subject><subject>cytotoxic</subject><subject>Cytotoxicity</subject><subject>Flow cytometry</subject><subject>In vivo methods and tests</subject><subject>Prostate cancer</subject><subject>Sulforhodamine</subject><subject>triterpene</subject><subject>Triterpenes</subject><subject>Tumor cell lines</subject><issn>1612-1872</issn><issn>1612-1880</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNqF0btOwzAUBuAIgcR1ZbbEAkOLb7l0LKFcJCQGCmvk2MdglNjBToq68QgMPCFPgqEIJBYm28fff2TrJMk-wWOCMT2WtVqMKaYM42LC1pItkhE6IkWB13_2Od1MtkN4jD7Wi63kbbYQzSB642xATqOp7Y0UVoJHM61B9l_V0rW1sb-qNKFr4tEiYRWaGz9I0TTCwvvL63zZAZp704PvwEJAl8FFCwpp71o0bbsH08XL5b0ZWiRU6L2x9xAbH97Ih6ZXzdFusqFFE2Dve91Jbs9m8_JidHV9fllOr0aS8ZSNeC3IRBcpIzmlnHPgutZUa0FlTSRwyDjDdZpmiihNIiokzyXOBdGgtMrYTnK46tt59zRA6KvWBAlfP3FDqGiRcZLmWU4iPfhDH93gbXxdVPmEM8YzHNV4paR3IXjQVedNK_yyIrj6HFL1OaTqZ0gxMFkFnk0Dy390VZ6c3v1mPwBW7Jnt</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Díaz‐Sánchez, Lidia</creator><creator>Zentella‐Dehesa, Alejandro</creator><creator>Castro‐Torres, Víctor Alberto</creator><creator>Silva‐Jiménez, Noemi</creator><creator>Jacobo‐Herrera, Nadia Judith</creator><creator>Martínez‐Vázquez, Mariano</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5595-1466</orcidid></search><sort><creationdate>202310</creationdate><title>Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane‐Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl)</title><author>Díaz‐Sánchez, Lidia ; Zentella‐Dehesa, Alejandro ; Castro‐Torres, Víctor Alberto ; Silva‐Jiménez, Noemi ; Jacobo‐Herrera, Nadia Judith ; Martínez‐Vázquez, Mariano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3453-4ba19f8531722444e4fbf2ffa2cb1ce4e6430b556d1df11728c47c07a1fedfd63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Anticancer properties</topic><topic>antitumor</topic><topic>Apoptosis</topic><topic>Biomedical materials</topic><topic>Cell proliferation</topic><topic>Cisplatin</topic><topic>Colon cancer</topic><topic>combinations</topic><topic>cytotoxic</topic><topic>Cytotoxicity</topic><topic>Flow cytometry</topic><topic>In vivo methods and tests</topic><topic>Prostate cancer</topic><topic>Sulforhodamine</topic><topic>triterpene</topic><topic>Triterpenes</topic><topic>Tumor cell lines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Díaz‐Sánchez, Lidia</creatorcontrib><creatorcontrib>Zentella‐Dehesa, Alejandro</creatorcontrib><creatorcontrib>Castro‐Torres, Víctor Alberto</creatorcontrib><creatorcontrib>Silva‐Jiménez, Noemi</creatorcontrib><creatorcontrib>Jacobo‐Herrera, Nadia Judith</creatorcontrib><creatorcontrib>Martínez‐Vázquez, Mariano</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Chemistry &amp; biodiversity</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Díaz‐Sánchez, Lidia</au><au>Zentella‐Dehesa, Alejandro</au><au>Castro‐Torres, Víctor Alberto</au><au>Silva‐Jiménez, Noemi</au><au>Jacobo‐Herrera, Nadia Judith</au><au>Martínez‐Vázquez, Mariano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane‐Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl)</atitle><jtitle>Chemistry &amp; biodiversity</jtitle><date>2023-10</date><risdate>2023</risdate><volume>20</volume><issue>10</issue><spage>e202300893</spage><epage>n/a</epage><pages>e202300893-n/a</pages><issn>1612-1872</issn><eissn>1612-1880</eissn><abstract>The cytotoxic activity of combinations of masticadienonic (AMD) or 3αOH‐hydroxy‐masticadienonic (3αOH‐AMD) acids with cisplatin (CDDP) was evaluated against PC3 prostate and HCT116 colon cancer cell lines. Combinations A (half the IC50 value), B (IC50 value), and C (twice the IC50 value) were tested at a 1 : 1 ratio. All AMD plus CDDP combinations demonstrated increased cytotoxic effect, as determined by the sulforhodamine B test, in both cell types. The best combination was B, which showed 93 % and 91 % inhibition of the proliferation of PC3 and HCT116 cells, respectively. It also increased apoptosis in the PC3 cell lines, as evaluated by flow cytometry. However, in vivo tests showed no additional activity from the AMD plus CDDP combinations. These results showed that the increased cytotoxic activity of the combinations in vitro did not reflect in vivo tests. All combinations of 3αOH‐AMD plus CDDP exerted antagonistic effects in both cell types.</abstract><cop>Weinheim</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/cbdv.202300893</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-5595-1466</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1612-1872
ispartof Chemistry & biodiversity, 2023-10, Vol.20 (10), p.e202300893-n/a
issn 1612-1872
1612-1880
language eng
recordid cdi_proquest_miscellaneous_2864157671
source Wiley Online Library Journals Frontfile Complete
subjects Anticancer properties
antitumor
Apoptosis
Biomedical materials
Cell proliferation
Cisplatin
Colon cancer
combinations
cytotoxic
Cytotoxicity
Flow cytometry
In vivo methods and tests
Prostate cancer
Sulforhodamine
triterpene
Triterpenes
Tumor cell lines
title Evaluations of Anticancer Effects of Combinations of Cisplatin and Tirucallane‐Type Triterpenes Isolated from Amphipterygium adstringens (Schltdl)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T19%3A54%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluations%20of%20Anticancer%20Effects%20of%20Combinations%20of%20Cisplatin%20and%20Tirucallane%E2%80%90Type%20Triterpenes%20Isolated%20from%20Amphipterygium%20adstringens%20(Schltdl)&rft.jtitle=Chemistry%20&%20biodiversity&rft.au=D%C3%ADaz%E2%80%90S%C3%A1nchez,%20Lidia&rft.date=2023-10&rft.volume=20&rft.issue=10&rft.spage=e202300893&rft.epage=n/a&rft.pages=e202300893-n/a&rft.issn=1612-1872&rft.eissn=1612-1880&rft_id=info:doi/10.1002/cbdv.202300893&rft_dat=%3Cproquest_cross%3E2864157671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2879433460&rft_id=info:pmid/&rfr_iscdi=true